Turning Point Therapeutics Clinical Trials
Determine Turning Point Therapeutics Inc go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.
A sample of Turning Point Therapeutics Clinical Trials data
| Trial Title | Trial Identifier | Drug Name | Therapy Area | Indication | Trial Phase | Trial Status | Sponsor |
|---|---|---|---|---|---|---|---|
| Deserunt mollit sunt Lorem | GDCTWXYZ | Lorem | Lorem | Lorem | WXYZ | Planned | Pfizer Inc |
| A Study of TPX-0131, A Novel Oral ALK Tyrosine Kinase Inhibitor, in Patients with ALK+ Advanced or Metastatic NSCLC | GDCT0417908 | TPX-0131 | Oncology | Non-Small Cell Lung Cancer; Solid Tumor | Phase I/II | Ongoing, not recruiting | Turning Point Therapeutics Inc |
| Phase I Study of Repotrectinib and Osimertinib in NSCLC Patients (TOTEM) | GDCT0414147 | repotrectinib | Oncology | Leptomeningeal Disease (Neoplastic Meningitis, Leptomeningeal Carcinomatosis); Non-Small Cell Lung Cancer; Solid Tumor | Phase I | Ongoing, recruiting | Dr Rosell Oncology Institute |
| A Study of Repotrectinib in Combination With Other Anticancer Therapies for the Treatment of Subjects With KRAS-Mutant Solid Tumors | GDCT0405849 | repotrectinib | Oncology | Non-Small Cell Lung Cancer; Solid Tumor | Phase I/II | Ongoing, not recruiting | Turning Point Therapeutics Inc |
Feature
GlobalData’s Clinical Trials database (CTDB) is a highly comprehensive source of Clinical Trials.
The database covers planned, ongoing, completed and terminated/suspended/withdrawn clinical trials.
Clinical Trials database provides intelligence on global clinical trials for all indications. The data is sourced from:
- 250+ clinical trial registries
- 200+ scientific and investor conferences, company pipelines, press releases, and SEC filings.
Benefit
The Clinical Trials database collects information on various parameters to provide a Clinical Trial overview as well as Clinical Trial details, Drug details, Patient details, Trial Results, Location(s)/Sponsor(s) and Contact Detail(s).
Access:
- Detailed trial information.
- Drug information.
- Patient information, including inclusion and exclusion criteria.
- Trial results, as reported in the public domain.
- Biomarkers used for patient stratification/selection & outcome measures.
- Enrolment parameters.
- Investigators involved in clinical trials.
- Trials sites and locations.
- Contact information.
Value
Competitive Activity – keep an eye on planned or ongoing trials, as well as the trials currently recruiting and who is sponsoring them.
Geographic Analysis - see where trials are being run.
Trend Analysis - view top sponsors, indications, phase, status and more with Trial Analytics.
Find information on trials contacts, as well as Site and Investigator information.
Get information on trial successes and failures.
Get intelligence on CROs engaged in clinical trials.
Use as a business development tool for CROs.
Premium databases is part of our industry range of products
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer